EGX: CPCI Statistics

Total Valuation

Kahira Pharmaceuticals & Chemical Industries Company has a market cap or net worth of EGP 1.74 billion. The enterprise value is 1.81 billion.

Market Cap	1.74B
Enterprise Value	1.81B

Important Dates

The last earnings date was Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	Dec 24, 2024

Share Statistics

Kahira Pharmaceuticals & Chemical Industries Company has 14.93 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	14.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	n/a
Float	2.73M

Valuation Ratios

The trailing PE ratio is 7.07.

PE Ratio	7.07
Forward PE	n/a
PS Ratio	1.28
PB Ratio	2.09
P/TBV Ratio	2.09
P/FCF Ratio	89.87
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.92, with an EV/FCF ratio of 93.45.

EV / Earnings	7.35
EV / Sales	1.33
EV / EBITDA	5.92
EV / EBIT	6.33
EV / FCF	93.45

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.29.

Current Ratio	2.25
Quick Ratio	1.04
Debt / Equity	0.29
Debt / EBITDA	0.78
Debt / FCF	12.28
Interest Coverage	15.08

Financial Efficiency

Return on equity (ROE) is 32.54% and return on invested capital (ROIC) is 18.65%.

Return on Equity (ROE)	32.54%
Return on Assets (ROA)	12.96%
Return on Capital (ROIC)	18.65%
Revenue Per Employee	722,704
Profits Per Employee	130,701
Employee Count	1,883
Asset Turnover	0.99
Inventory Turnover	1.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +102.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+102.26%
50-Day Moving Average	103.19
200-Day Moving Average	79.98
Relative Strength Index (RSI)	75.55
Average Volume (20 Days)	4,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kahira Pharmaceuticals & Chemical Industries Company had revenue of EGP 1.36 billion and earned 246.11 million in profits. Earnings per share was 16.48.

Revenue	1.36B
Gross Profit	517.66M
Operating Income	285.67M
Pretax Income	315.35M
Net Income	246.11M
EBITDA	301.14M
EBIT	285.67M
Earnings Per Share (EPS)	16.48

Full Income Statement

Balance Sheet

The company has 168.28 million in cash and 237.53 million in debt, giving a net cash position of -69.25 million or -4.64 per share.

Cash & Cash Equivalents	168.28M
Total Debt	237.53M
Net Cash	-69.25M
Net Cash Per Share	-4.64
Equity (Book Value)	832.49M
Book Value Per Share	55.74
Working Capital	587.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 262.89 million and capital expenditures -243.54 million, giving a free cash flow of 19.35 million.

Operating Cash Flow	262.89M
Capital Expenditures	-243.54M
Free Cash Flow	19.35M
FCF Per Share	1.30

Full Cash Flow Statement

Margins

Gross margin is 38.04%, with operating and profit margins of 20.99% and 18.09%.

Gross Margin	38.04%
Operating Margin	20.99%
Pretax Margin	23.17%
Profit Margin	18.09%
EBITDA Margin	22.13%
EBIT Margin	20.99%
FCF Margin	1.42%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 6.01%.

Dividend Per Share	7.00
Dividend Yield	6.01%
Dividend Growth (YoY)	-9.58%
Years of Dividend Growth	n/a
Payout Ratio	34.75%
Buyback Yield	n/a
Shareholder Yield	6.01%
Earnings Yield	14.15%
FCF Yield	1.11%

Dividend Details

Stock Splits

The last stock split was on September 10, 2020. It was a forward split with a ratio of 1.25.

Last Split Date	Sep 10, 2020
Split Type	Forward
Split Ratio	1.25

Scores

Kahira Pharmaceuticals & Chemical Industries Company has an Altman Z-Score of 3.24.

Altman Z-Score	3.24
Piotroski F-Score	n/a